Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update
Alice Nervo, Francesca Retta, Alberto Ragni, Alessandro Piovesan, Alberto Mella, Luigi Biancone, Marco Manganaro, Marco Gallo, Emanuela Arvat
Topics & Concepts
MedicineAdverse effectCabozantinibThyroid cancerIntensive care medicineAxitinibNephrotoxicityCancerClinical trialLenvatinibSunitinibOncologyToxicityInternal medicineThyroid Cancer Diagnosis and TreatmentRenal cell carcinoma treatmentCoagulation, Bradykinin, Polyphosphates, and Angioedema